To ask the Secretary of State for Health and Social Care, what assessment he has made of the cost effectiveness of the use of abiraterone as a treatment for prostate cancer by the NHS.
The National Institute for Health and Care Excellence (NICE) is the independent body that provides evidence-based guidance for the National Health Service on whether new medicines represent a clinically- and cost-effective use of resources. The NHS is leg...
Abiraterone